- Home
- ORGO vs GPRE Comparison
ORGO vs GPRE Comparison
Compare ORGO & GPRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- GPRE
- Stock Information
- Founded
- ORGO 1985
- GPRE 2004
- Country
- ORGO United States
- GPRE United States
- Employees
- ORGO N/A
- GPRE N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- GPRE Major Chemicals
- Sector
- ORGO Health Care
- GPRE Industrials
- Exchange
- ORGO Nasdaq
- GPRE Nasdaq
- Market Cap
- ORGO 465.6M
- GPRE 542.8M
- IPO Year
- ORGO N/A
- GPRE N/A
- Fundamental
- Price
- ORGO $4.51
- GPRE $7.88
- Analyst Decision
- ORGO Buy
- GPRE Buy
- Analyst Count
- ORGO 2
- GPRE 7
- Target Price
- ORGO $6.50
- GPRE $10.42
- AVG Volume (30 Days)
- ORGO 895.4K
- GPRE 1.4M
- Earning Date
- ORGO 08-07-2025
- GPRE 08-12-2025
- Dividend Yield
- ORGO N/A
- GPRE N/A
- EPS Growth
- ORGO N/A
- GPRE N/A
- EPS
- ORGO N/A
- GPRE N/A
- Revenue
- ORGO $458,760,000.00
- GPRE $2,463,097,000.00
- Revenue This Year
- ORGO $3.50
- GPRE $1.80
- Revenue Next Year
- ORGO $8.59
- GPRE $2.92
- P/E Ratio
- ORGO N/A
- GPRE N/A
- Revenue Growth
- ORGO 5.35
- GPRE N/A
- 52 Week Low
- ORGO $2.28
- GPRE $3.14
- 52 Week High
- ORGO $6.71
- GPRE $17.84
- Technical
- Relative Strength Index (RSI)
- ORGO 53.20
- GPRE 58.03
- Support Level
- ORGO $4.67
- GPRE $7.92
- Resistance Level
- ORGO $5.15
- GPRE $8.75
- Average True Range (ATR)
- ORGO 0.28
- GPRE 0.38
- MACD
- ORGO -0.04
- GPRE -0.10
- Stochastic Oscillator
- ORGO 53.70
- GPRE 27.50
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.